Cozad Asset Management Inc. Reduces Holdings in Cardinal Health, Inc. (NYSE:CAH)

Cozad Asset Management Inc. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 25,850 shares of the company’s stock after selling 1,028 shares during the period. Cozad Asset Management Inc.’s holdings in Cardinal Health were worth $3,057,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Rothschild Investment LLC boosted its stake in Cardinal Health by 10.1% during the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock worth $101,000 after buying an additional 79 shares during the last quarter. Private Trust Co. NA boosted its stake in Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after buying an additional 92 shares during the last quarter. Checchi Capital Advisers LLC boosted its stake in Cardinal Health by 2.7% during the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock worth $411,000 after buying an additional 93 shares during the last quarter. MWA Asset Management boosted its stake in Cardinal Health by 2.9% during the fourth quarter. MWA Asset Management now owns 3,324 shares of the company’s stock worth $393,000 after buying an additional 95 shares during the last quarter. Finally, Transcend Capital Advisors LLC boosted its stake in Cardinal Health by 3.6% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock worth $323,000 after buying an additional 96 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 1.5 %

CAH opened at $128.20 on Monday. The stock’s 50-day moving average price is $126.33 and its 200 day moving average price is $119.44. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84. The firm has a market cap of $30.97 billion, a price-to-earnings ratio of 23.92, a PEG ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.58%. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CAH. JPMorgan Chase & Co. boosted their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company upped their price target on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research note on Tuesday, January 7th. Citigroup upped their price target on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Finally, Mizuho began coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target on the stock. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.